Patterns of white matter atrophy in frontotemporal lobar degeneration

Linda L Chao1, Norbert Schuff, Erin M Clevenger

  • 1Center for Imaging of Neurodegenerative Diseases, San Francisco Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA. linda.chao@ucsf.edu

Archives of Neurology
|November 14, 2007
PubMed
Abstract

Insights

Frontotemporal lobar degeneration involves white matter (WM) and gray matter (GM) atrophy. This study found WM atrophy patterns parallel GM atrophy in early-stage frontotemporal dementia and semantic dementia.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Structural magnetic resonance imaging (MRI) is crucial for studying frontotemporal lobar degeneration (FTLD) pathology.
  • Limited research has explored white matter (WM) alterations in FTLD.
  • This study investigates WM changes in FTD and semantic dementia.

Purpose of the Study:

  • To identify in vivo patterns of WM atrophy in frontotemporal dementia (FTD) and semantic dementia using volumetric MRI.
  • To compare WM atrophy patterns with gray matter (GM) atrophy in these FTLD variants.

Main Methods:

  • Structural MRIs (T1, T2, proton density-weighted) were acquired from patients with FTD (n=12), semantic dementia (n=13), and healthy controls (n=24).
  • Regional GM and WM volumes were automatically classified using Expectation-Maximization Segmentation.
  • Group comparisons utilized multivariate analysis of covariance, controlling for age and WM lesion volumes.

Main Results:

  • Patients with FTD exhibited frontal WM atrophy and widespread GM atrophy (frontal, parietal, temporal).
  • Patients with semantic dementia showed temporal WM and GM atrophy.
  • Including temporal WM volume significantly enhanced the differentiation between semantic dementia and FTD.

Conclusions:

  • Early-stage frontotemporal lobar degeneration (Clinical Dementia Rating score 1.0-1.2) demonstrates WM atrophy.
  • The observed WM atrophy patterns closely mirror the established GM atrophy patterns in these disorders.
  • WM atrophy is a significant feature in early FTD and semantic dementia, aiding in differential diagnosis.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Association Areas of the Cortex01:21

Association Areas of the Cortex

Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...